T1	SectionAnnotate 0 4	HPI:
T2	SectionAnnotate 2713 2735	Past Surgical History:
T3	SectionSkip 2939 3278	Current Outpatient Prescriptions:     ALPRAZolam (XANAX) 0.25 mg tablet, , Disp: , Rfl:     ibuprofen (ADVIL) 200 mg tablet, Take 200 mg by mouth every 6 (six) hours., Disp: , Rfl:     trazodone HCl (TRAZODONE ORAL), Take 0.5 tablets by mouth., Disp: , Rfl:   No current facility-administered medications for this visit.     Gynecologic
T4	SectionAnnotate 3405 3419	Social History
T5	SectionAnnotate 3424 3448	Social History Narrative
T6	SectionAnnotate 3736 3750	Family History
T7	SectionAnnotate 3912 3915	ROS
T8	SectionSkip 4268 5582	Physical Examination: General appearance - alert, well appearing, and in no distress  BP 128/72  | Pulse 92  | Temp 36.6 C (97.9 F) (Oral)  | Resp 18  | Ht 157.5 cm (5' 2.01") Comment: March 2018 @ ***** | Wt 57.9 kg (127 lb 11.2 oz)  | SpO2 100%  | BMI 23.35 kg/m     Mental status - normal mood, behavior, speech, dress, motor activity, and thought processes  Eyes - pupils equal and reactive, extraocular eye movements intact  Mouth - mucous membranes moist, pharynx normal without lesions  Neck - supple, no significant adenopathy  Lymphatics - no palpable lymphadenopathy  Chest - clear to auscultation, no wheezes, rales or rhonchi, symmetric air entry  Heart - normal rate and regular rhythm, no murmurs noted  Abdomen - soft, nontender, nondistended, no masses or organomegaly  Breasts - Deferred today by me since she has had multiple exams today already  Back exam - full range of motion, no tenderness, palpable spasm or pain on motion  Neurological - cranial nerves II through XII intact, motor and sensory grossly normal bilaterally  Musculoskeletal - no joint tenderness, deformity or swelling, no muscular tenderness noted  Extremities - no pedal edema noted  Skin - No rashes      Imaging results reviewed and discussed with patient:    Exam Date: 03/16/2018    Exam(s): MR breast bilateral en + un
T9	SectionSkip 6507 7621	Findings:  This bilateral breast MRI exam demonstrates mild background enhancement.  The breasts are composed of heterogeneous fibroglandular tissue and fat.    RIGHT Breast:  There is a 9 mm oval mass with smooth margins and dark internal septation in the upper outer right breast. Signal intensity/time curve demonstrates slow initial rise and persistent enhancement kinetics.All findings classic for fibroadenoma.  No abnormal areas of enhancement or other MRI features of malignancy are identified. Findings are best seen on post-contrast axial image #66 and sagittal image #603.    LEFT Breast:  There is a 2.5 cm (AP) x 2.2 cm (TV) x 2.3 cm (CC) oval mass with irregular margins and heterogeneous enhancement in the lower outer left breast. Signal intensity/time curve demonstrates rapid initial rise and washout enhancement kinetics. Findings are best seen on post-contrast axial image #87 and sagittal image #118.    Other: At least two abnormal lymph nodes in the left axilla level I and I/II with cortical thickening, measuring up to 6 mm. Findings are best seen on post-contrast axial images #24 and 55.
T10	SectionAnnotate 7625 7636	IMPRESSION:
T11	SectionSkip 7846 7904	Pathology results reviewed and discussed with the patient:
T12	SectionAnnotate 7908 7928	Assessment and Plan:
T13	TREATMENT 63 80	treatment options
T14	PROBLEM 85 122	recently diagnosed left breast cancer
T15	TEST 170 185	genetic testing
T16	PROBLEM 225 238	breast cancer
T17	PROBLEM 299 309	a mutation
T18	PROBLEM 394 412	a left breast lump
T19	TEST 448 464	a left breast US
T20	PROBLEM 499 529	an irregularly marginated mass
T21	PROBLEM 535 555	internal vascularity
T22	TEST 600 625	left diagnostic mammogram
T23	PROBLEM 653 676	an irregular 15 mm mass
T24	TEST 728 733	an US
T25	TEST 741 752	core biopsy
T26	PROBLEM 756 776	the left breast mass
T27	PROBLEM 807 842	a grade 2 invasive ductal carcinoma
T28	PROBLEM 858 868	The cancer
T29	TEST 892 894	PR
T30	TEST 911 915	HER2
T31	TEST 936 940	Ki67
T32	TEST 962 982	an US of left axilla
T33	PROBLEM 989 1009	multiple lymph nodes
T34	PROBLEM 1098 1107	echogenic
T35	PROBLEM 1120 1149	The two slightly larger nodes
T36	PROBLEM 1188 1204	a hypoechoic rim
T37	PROBLEM 1209 1233	architectural distortion
T38	TEST 1258 1264	an FNA
T39	PROBLEM 1268 1294	a left axillary lymph node
T40	PROBLEM 1364 1394	a few benign mesenchymal cells
T41	PROBLEM 1408 1419	lymphocytes
T42	TEST 1424 1454	peripheral blood cell elements
T43	PROBLEM 1463 1478	malignant cells
T44	TEST 1507 1545	a diagnostic mammogram of right breast
T45	PROBLEM 1568 1578	malignancy
T46	TEST 1674 1694	bilateral breast MRI
T47	PROBLEM 1738 1754	a 9 mm oval mass
T48	PROBLEM 1760 1774	smooth margins
T49	PROBLEM 1779 1834	dark internal septation in the upper outer right breast
T50	PROBLEM 1861 1873	fibroadenoma
T51	PROBLEM 1888 1917	abnormal areas of enhancement
T52	PROBLEM 1945 1969	malignancy  on the right
T53	PROBLEM 2000 2037	a 2.5 cm x 2.2 cm  x 2.3 cm oval mass
T54	PROBLEM 2043 2060	irregular margins
T55	PROBLEM 2065 2121	heterogeneous enhancement in the lower outer left breast
T56	PROBLEM 2146 2170	two abnormal lymph nodes
T57	PROBLEM 2212 2231	cortical thickening
T58	TREATMENT 2354 2376	this patient radiation
T59	TREATMENT 2386 2402	her ATM mutation
T60	TREATMENT 2447 2457	mastectomy
T61	TEST 2517 2529	a repeat FNA
T62	TREATMENT 2579 2593	the Mammaprint
T63	TEST 2599 2620	her prior core biopsy
T64	TREATMENT 2768 2796	Colposcopy         Allergies
T65	TREATMENT 2898 2928	Sulfa (Sulfonamide Antibiotics
T66	TREATMENT 2978 2996	ALPRAZolam (XANAX)
T67	TREATMENT 3033 3050	ibuprofen (ADVIL)
T68	TREATMENT 3127 3157	trazodone HCl (TRAZODONE ORAL)
T69	TREATMENT 3235 3246	medications
T70	TREATMENT 3350 3362	Depo-Provera
T71	TREATMENT 3367 3386	oral contraceptives
T72	PROBLEM 3792 3805	Breast cancer
T73	PROBLEM 3819 3832	Breast cancer
T74	PROBLEM 3845 3858	Breast cancer
T75	PROBLEM 3957 3968	Nervousness
T76	PROBLEM 3972 3979	Anxiety
T77	PROBLEM 3986 4003	Sleep disturbance
T78	PROBLEM 4025 4036	sore throat
T79	PROBLEM 4038 4054	nasal congestion
T80	PROBLEM 4056 4070	vision changes
T81	PROBLEM 4072 4077	cough
T82	PROBLEM 4079 4089	chest pain
T83	PROBLEM 4091 4098	dyspnea
T84	PROBLEM 4100 4106	nausea
T85	PROBLEM 4108 4116	vomiting
T86	PROBLEM 4118 4132	abdominal pain
T87	PROBLEM 4134 4143	headaches
T88	PROBLEM 4145 4151	fevers
T89	PROBLEM 4157 4192	change in bladder or bowel function
T90	PROBLEM 4344 4352	distress
T91	TEST 4354 4356	BP
T92	TEST 4367 4372	Pulse
T93	TEST 4379 4383	Temp
T94	TEST 4389 4390	C
T95	TEST 4410 4414	Resp
T96	TEST 4421 4423	Ht
T97	TEST 4474 4476	Wt
T98	TEST 4505 4509	SpO2
T99	TEST 4518 4521	BMI
T100	TEST 4537 4550	Mental status
T101	TEST 4664 4689	extraocular eye movements
T102	PROBLEM 4753 4760	lesions
T103	PROBLEM 4780 4802	significant adenopathy
T104	PROBLEM 4820 4844	palpable lymphadenopathy
T105	TEST 4863 4875	auscultation
T106	PROBLEM 4880 4887	wheezes
T107	PROBLEM 4889 4894	rales
T108	PROBLEM 4898 4905	rhonchi
T109	PROBLEM 4971 4978	murmurs
T110	PROBLEM 5002 5011	nontender
T111	PROBLEM 5013 5025	nondistended
T112	PROBLEM 5030 5036	masses
T113	PROBLEM 5040 5052	organomegaly
T114	TEST 5103 5117	multiple exams
T115	TEST 5133 5142	Back exam
T116	PROBLEM 5170 5180	tenderness
T117	PROBLEM 5182 5196	palpable spasm
T118	PROBLEM 5200 5204	pain
T119	PROBLEM 5336 5352	joint tenderness
T120	PROBLEM 5354 5363	deformity
T121	PROBLEM 5367 5375	swelling
T122	PROBLEM 5380 5399	muscular tenderness
T123	PROBLEM 5424 5435	pedal edema
T124	PROBLEM 5453 5459	rashes
T125	TEST 5555 5557	MR
T126	PROBLEM 5634 5646	ATM mutation
T127	TEST 5674 5684	evaluation
T128	PROBLEM 5698 5705	disease
T129	TEST 5723 5740	Prior examination
T130	TEST 5790 5793	MRI
T131	TEST 5806 5831	Bilateral 1.5T breast MRI
T132	TEST 5973 5987	fat saturation
T133	TEST 6050 6081	dynamic post-contrast sequences
T134	TREATMENT 6083 6108	Gadolinium based contrast
T135	PROBLEM 6196 6212	adverse reaction
T136	TEST 6217 6226	The study
T137	TEST 6503 6506	MRI
T138	TEST 6518 6548	This bilateral breast MRI exam
T139	PROBLEM 6562 6589	mild background enhancement
T140	PROBLEM 6620 6655	heterogeneous fibroglandular tissue
T141	PROBLEM 6692 6708	a 9 mm oval mass
T142	PROBLEM 6714 6728	smooth margins
T143	PROBLEM 6733 6788	dark internal septation in the upper outer right breast
T144	TEST 6790 6817	Signal intensity/time curve
T145	PROBLEM 6831 6848	slow initial rise
T146	PROBLEM 6853 6884	persistent enhancement kinetics
T147	PROBLEM 6910 6922	fibroadenoma
T148	PROBLEM 6928 6957	abnormal areas of enhancement
T149	PROBLEM 6983 6993	malignancy
T150	TEST 7036 7061	post-contrast axial image
T151	TEST 7070 7084	sagittal image
T152	PROBLEM 7117 7168	a 2.5 cm (AP) x 2.2 cm (TV) x 2.3 cm (CC) oval mass
T153	PROBLEM 7174 7191	irregular margins
T154	PROBLEM 7196 7252	heterogeneous enhancement in the lower outer left breast
T155	TEST 7254 7281	Signal intensity/time curve
T156	PROBLEM 7295 7346	rapid initial rise and washout enhancement kinetics
T157	TEST 7374 7399	post-contrast axial image
T158	TEST 7408 7422	sagittal image
T159	PROBLEM 7448 7472	two abnormal lymph nodes
T160	PROBLEM 7514 7533	cortical thickening
T161	TEST 7583 7609	post-contrast axial images
T162	PROBLEM 7652 7682	Known biopsy proven malignancy
T163	TEST 7684 7691	BI-RADS
T164	TREATMENT 7765 7808	continued 
 surgical/oncological management
T165	PROBLEM 7813 7841	knwon left breast malignancy
T166	TEST 8093 8105	a second FNA
T167	PROBLEM 8154 8160	cancer
T168	PROBLEM 8173 8189	her ATM mutation
T169	TREATMENT 8191 8209	radiation oncology
T170	TREATMENT 8248 8258	mastectomy
T171	TREATMENT 8271 8296	breast conserving surgery
T172	PROBLEM 8324 8343	the patient's tumor
T173	TREATMENT 8389 8401	chemotherapy
T174	PROBLEM 8445 8455	truly node
T175	TREATMENT 8480 8487	surgery
T176	TREATMENT 8506 8514	Taxotere
T177	TREATMENT 8519 8526	Cytoxan
T178	PROBLEM 8546 8559	node positive
T179	TREATMENT 8576 8584	AC-Taxol
T180	TREATMENT 8653 8665	chemotherapy
T181	TREATMENT 8688 8695	surgery
T182	PROBLEM 8883 8893	toxicities
T183	TREATMENT 8898 8920	various chemotherapies
T184	TREATMENT 8979 8986	surgery
T185	PROBLEM 8999 9016	her breast cancer
T186	PROBLEM 9020 9046	estrogen receptor positive
T187	TREATMENT 9109 9134	adjuvant hormonal therapy
T188	PROBLEM 9397 9413	ovarian function
T189	TREATMENT 9434 9446	chemotherapy
T190	TREATMENT 9467 9486	ovarian suppression
T191	TREATMENT 9491 9513	an aromatase inhibitor
T192	TREATMENT 9530 9539	tamoxifen
T193	PROBLEM 9563 9581	distant recurrence
T194	TEST 9621 9635	the SOFT trial
T195	TEST 9666 9679	survival rate
T196	TREATMENT 9695 9704	tamoxifen
T197	TREATMENT 9725 9759	tamoxifen plus ovarian suppression
T198	TREATMENT 9776 9811	exemestane plus ovarian suppression
T199	TREATMENT 9825 9834	tamoxifen
T200	TREATMENT 9845 9879	tamoxifen plus ovarian suppression
T201	PROBLEM 9903 9924	HER2 negative cancers
T202	TREATMENT 9938 9950	chemotherapy
T203	PROBLEM 9971 9989	distant recurrence
T204	TREATMENT 9995 10030	exemestane plus ovarian suppression
T205	TREATMENT 10060 10094	tamoxifen plus ovarian suppression
T206	TREATMENT 10232 10248	hormonal therapy
T207	TREATMENT 10255 10262	surgery
T208	TREATMENT 10375 10392	Treatment options
T209	PROBLEM 10394 10406	side effects
T210	ClinicalCondition 109 122	breast cancer
T211	Site 104 108	left
T212	ClinicalCondition 225 238	breast cancer
A3	ExperiencerVal T212 family
T213	GenomicTest 170 185	genetic testing
A4	IntentVal T213 screening
A5	GenomicTestType T213 Unclear
T214	Datetime 189 199	early 2018
R1	HappensAtOnDuring Arg1:T213 Arg2:T214	
R2	TestOrProcedureConductedForProblem Test:T213 Prob:T212	
T215	GenomicTestResult 301 361	mutation in the ATM gene (c1109dup (p.Tyr370*) heterozygous)
T216	Symptom 408 412	lump
A6	IsPresentOnFirstCancerDiagnosis T216 yes
A7	IsCausedByDiagnosedCancer T216 yes
A8	ChronicVal T216 non-chronic
A9	ContinuityVal T216 new
T217	Site 401 407	breast
T218	Laterality 396 400	left
R4	LateralityOfSite Arg1:T218 Arg2:T217	
R5	SiteOf Arg1:T217 Arg2:T216	
T219	Radiology 462 464	US
A10	IntentVal T219 diagnosis
T220	Site 455 461	breast
T221	Laterality 450 454	left
T222	Datetime 438 446	01/10/18
R6	SiteOf Arg1:T220 Arg2:T219	
R7	LateralityOfSite Arg1:T221 Arg2:T220	
R8	HappensAtOnDuring Arg1:T219 Arg2:T222	
T223	RadPathResult 502 555	irregularly marginated mass with internal vascularity
A11	RadPathResultVal T223 InitialCancerDiagnosis
R9	ResultOfTest Desc:T223 Test:T219	
T224	Site 559 586	5:00, 4-5cm from the nipple
R10	SiteOf Arg1:T224 Arg2:T223	
T225	Radiology 616 625	mammogram
A12	IntentVal T225 diagnosis
T226	Laterality 600 604	left
T227	Datetime 591 599	01/12/18
R11	HappensAtOnDuring Arg1:T225 Arg2:T227	
T228	Size 666 671	15 mm
A13	HistoryVal T228 new
A14	EpisodeDescription T228 FirstOccurrence
T229	RadPathResult 672 676	mass
A15	RadPathResultVal T229 InitialCancerDiagnosis
T230	Site 680 710	5 o'clock, 5cm from the nipple
R12	ResultOfTest Desc:T229 Test:T225	
R13	TestOrProcedureReveals Test:T225 Desc:T228	
R14	SiteOf Arg1:T230 Arg2:T229	
R15	LateralityOfSite Arg1:T226 Arg2:T230	
T231	Pathology 731 752	US-guided core biopsy
A16	IntentVal T231 diagnosis
T232	Datetime 719 727	01/24/18
R16	HappensAtOnDuring Arg1:T231 Arg2:T232	
T233	Site 765 776	breast mass
T234	Laterality 760 764	left
R17	LateralityOfSite Arg1:T234 Arg2:T233	
R18	SiteOf Arg1:T233 Arg2:T231	
T235	Grade 815 816	2
A17	HistoryVal T235 new
A18	EpisodeDescription T235 FirstOccurrence
T236	Histology 817 842	invasive ductal carcinoma
A19	HistoryVal T236 new
A20	EpisodeDescription T236 FirstOccurrence
T237	Size 853 856	8mm
A21	HistoryVal T237 new
A22	EpisodeDescription T237 FirstOccurrence
R19	TestOrProcedureReveals Test:T231 Desc:T235	
R20	TestOrProcedureReveals Test:T231 Desc:T236	
R21	TestOrProcedureReveals Test:T231 Desc:T237	
T238	BiomarkerName 872 874	ER
A23	HistoryVal T238 new
A24	EpisodeDescription T238 FirstOccurrence
T239	BiomarkerResult 875 890	positive (>95%)
A25	HistoryVal T239 new
A26	EpisodeDescription T239 FirstOccurrence
A27	BiomarkerResultVal T239 Positive
T240	BiomarkerName 892 894	PR
A28	HistoryVal T240 new
A29	EpisodeDescription T240 FirstOccurrence
T241	BiomarkerResult 895 903	positive
A30	HistoryVal T241 new
A31	EpisodeDescription T241 FirstOccurrence
A32	BiomarkerResultVal T241 Positive
T242	BiomarkerName 911 915	HER2
A33	HistoryVal T242 new
A34	EpisodeDescription T242 FirstOccurrence
T243	BiomarkerResult 916 924	negative
A35	HistoryVal T243 new
A36	EpisodeDescription T243 FirstOccurrence
A37	BiomarkerResultVal T243 Negative
R22	BiomarkerRel Arg1:T238 Arg2:T239	
R23	BiomarkerRel Arg1:T240 Arg2:T241	
R24	BiomarkerRel Arg1:T242 Arg2:T243	
R25	TestOrProcedureReveals Test:T231 Desc:T238	
R26	TestOrProcedureReveals Test:T231 Desc:T240	
R27	TestOrProcedureReveals Test:T231 Desc:T242	
T244	Radiology 965 967	US
A38	IntentVal T244 staging
T245	Site 976 982	axilla
T246	Laterality 971 975	left
T247	Datetime 952 960	02/06/18
R28	LateralityOfSite Arg1:T246 Arg2:T245	
R29	SiteOf Arg1:T245 Arg2:T244	
R30	HappensAtOnDuring Arg1:T244 Arg2:T247	
T250	RadPathResult 1029 1046;1060 1077;989 1009	1.2 x 1.5 x 0.5cm 0.5 x 0.5 x 0.4cm multiple lymph nodes
R33	TestOrProcedureReveals Test:T244 Desc:T250	
T251	Pathology 1261 1264	FNA
A45	IntentVal T251 staging
T252	Datetime 1248 1256	02/14/18
R34	HappensAtOnDuring Arg1:T251 Arg2:T252	
T253	Site 1275 1294	axillary lymph node
T254	Laterality 1270 1274	left
R35	LateralityOfSite Arg1:T254 Arg2:T253	
T255	RadPathResult 1335 1341	benign
A46	RadPathResultVal T255 NoDisease
R36	ResultOfTest Desc:T255 Test:T251	
R37	SiteOf Arg1:T211 Arg2:T210	
T256	Age 260 262	30
R38	HappensAtOnDuring Arg1:T212 Arg2:T256	
T257	Datetime 366 379	December 2017
R39	HappensAtOnDuring Arg1:T216 Arg2:T257	
T259	Pathology 929 933	FISH
T260	Pathology 936 940	Ki67
T261	RadPathResult 941 944	44%
R40	ResultOfTest Desc:T261 Test:T260	
T262	Histology 1463 1478	malignant cells
A50	NegationModalityVal T262 negated
T263	RadPathResult 1370 1376	benign
A51	RadPathResultVal T263 NoDisease
R41	ResultOfTest Desc:T263 Test:T251	
T264	Datetime 1497 1505	02/17/18
T265	Datetime 1583 1591	02/22/18
T266	Radiology 1520 1529	mammogram
A52	IntentVal T266 diagnosis
T267	Site 1539 1545	breast
T268	Laterality 1533 1538	right
R42	LateralityOfSite Arg1:T268 Arg2:T267	
R43	SiteOf Arg1:T267 Arg2:T266	
T269	RadPathResult 1568 1578	malignancy
A53	RadPathResultVal T269 NoDisease
A54	NegationModalityVal T269 negated
R44	HappensAtOnDuring Arg1:T266 Arg2:T264	
R45	ResultOfTest Desc:T269 Test:T266	
T270	Datetime 1698 1706	03/16/18
T271	Radiology 1691 1694	MRI
A55	IntentVal T271 diagnosis
T272	Site 1684 1690	breast
T273	Laterality 1674 1683	bilateral
R46	LateralityOfSite Arg1:T273 Arg2:T272	
R47	SiteOf Arg1:T272 Arg2:T271	
R48	HappensAtOnDuring Arg1:T271 Arg2:T270	
T274	Site 1721 1727	breast
T275	Laterality 1715 1720	right
R49	LateralityOfSite Arg1:T275 Arg2:T274	
T276	RadPathResult 1745 1754	oval mass
A56	RadPathResultVal T276 Others
T277	Size 1740 1744	9 mm
R50	ResultOfTest Desc:T276 Test:T271	
T278	Site 1810 1821;1828 1834	upper outer breast
T279	Laterality 1822 1827	right
R51	LateralityOfSite Arg1:T279 Arg2:T278	
R52	SiteOf Arg1:T278 Arg2:T276	
R53	SiteOf Arg1:T274 Arg2:T276	
T280	Histology 1861 1873	fibroadenoma
T281	RadPathResult 1945 1955	malignancy
A57	RadPathResultVal T281 NoDisease
A58	NegationModalityVal T281 negated
R54	ResultOfTest Desc:T281 Test:T271	
T282	Site 1983 1989	breast
T283	Laterality 1978 1982	LEFT
R55	LateralityOfSite Arg1:T283 Arg2:T282	
T284	RadPathResult 2028 2037	oval mass
T285	Size 2002 2027	2.5 cm x 2.2 cm  x 2.3 cm
T286	TumorCharacteristics 1760 1802	smooth margins and dark internal septation
T287	TumorCharacteristics 2043 2090	irregular margins and heterogeneous enhancement
R56	ResultOfTest Desc:T284 Test:T271	
T288	Site 2098 2109;2115 2121	lower outer breast
T289	Laterality 2110 2114	left
R58	LateralityOfSite Arg1:T289 Arg2:T288	
R59	SiteOf Arg1:T288 Arg2:T284	
T290	LymphNodeInvolvement 2146 2170	two abnormal lymph nodes
T291	Site 2183 2189	axilla
T292	Laterality 2178 2182	left
R61	LateralityOfSite Arg1:T292 Arg2:T291	
R62	SiteOf Arg1:T291 Arg2:T290	
T293	Size 2249 2253	6 mm
T294	RadiationTherapyName 2367 2376	radiation
A59	NegationModalityVal T294 hypothetical_in_future
T295	GenomicTestResult 2390 2402	ATM mutation
R63	NotUndergoneBecauseOf Arg1:T294 Reason:T295	
T296	ProcedureName 2447 2457	mastectomy
A60	NegationModalityVal T296 hypothetical_in_future
A61	IntentVal T296 treatment-curative
A62	TreatmentTypeVal T296 local
T297	Pathology 2526 2529	FNA
A63	IntentVal T297 diagnosis
T298	Site 2542 2548	axilla
T299	Laterality 2537 2541	left
R64	SiteOf Arg1:T298 Arg2:T297	
R65	LateralityOfSite Arg1:T299 Arg2:T298	
T300	GenomicTest 2583 2593	Mammaprint
A64	IntentVal T300 others
A65	GenomicTestType T300 GeneExpression
T301	GenomicTestResult 2634 2652	High Risk (-0.622)
R66	ResultOfTest Desc:T301 Test:T300	
T302	GenomicTest 268 287	Myriad myRisk panel
R3	ResultOfTest Desc:T215 Test:T302	
R67	TestOrProcedureConductedForProblem Test:T302 Prob:T212	
A66	IntentVal T302 screening
A67	GenomicTestType T302 GeneExpression
R68	TestOrProcedureConductedForProblem Test:T219 Prob:T216	
R69	TestOrProcedureConductedForProblem Test:T225 Prob:T216	
R70	TestOrProcedureConductedForProblem Test:T231 Prob:T216	
R71	TestOrProcedureConductedForProblem Test:T251 Prob:T250	
R31	TestOrProcedureReveals Test:T271 Desc:T280	
T248	Pathology 2609 2620	core biopsy
A39	IntentVal T248 diagnosis
T249	SectionSkip 2787 2929	Allergies/Contraindications   Allergen Reactions    Nut (All) Anaphylaxis     Almonds     Corn     Soy     Sulfa (Sulfonamide Antibiotics)
A40	SectionSkipType T249 allergies
T303	ProcedureName 2768 2778	Colposcopy
T304	ClinicalCondition 3288 3296	Menarche
T305	Datetime 3307 3318	February 16
R32	BeginsOnOrAt Arg1:T304 Arg2:T305	
T306	PatientCharacteristics 3331 3335	G2P2
T307	PatientCharacteristics 3350 3362	Depo-Provera
T308	PatientCharacteristics 3367 3386	oral contraceptives
T309	Employment 3452 3485	Manager of jewelry store in *****
A41	IsStoppedOrContinuing T309 continuing
T310	Tobacco 3521 3534	Former Smoker
A42	IsStoppedOrContinuing T310 stopped
T311	ConsumptionQuantity 3550 3554	0.20
R72	ConsumptionQuantityRel Arg1:T310 Arg2:T311	
T312	Duration 3559 3571	Years: 10.00
T313	Datetime 3588 3598	03/07/2002
T314	Datetime 3614 3624	08/05/2012
R73	HappensAtOnDuring Arg1:T310 Arg2:T312	
R74	BeginsOnOrAt Arg1:T310 Arg2:T313	
R75	EndsOnOrAt Arg1:T310 Arg2:T314	
T315	Alcohol 3715 3720	drank
A44	IsStoppedOrContinuing T315 stopped
T316	ConsumptionQuantity 3721 3729	4 a week
R76	ConsumptionQuantityRel Arg1:T315 Arg2:T316	
T317	ClinicalCondition 3792 3805	Breast cancer
A68	ExperiencerVal T317 family
T318	ClinicalCondition 3819 3832	Breast cancer
A69	ExperiencerVal T318 family
T319	ClinicalCondition 3845 3858	Breast cancer
A70	ExperiencerVal T319 family
T320	Symptom 3957 3968	Nervousness
T321	Symptom 3972 3979	Anxiety
T322	Symptom 3986 4003	Sleep disturbance
T323	GenomicTestResult 5634 5646	ATM mutation
T324	Histology 5656 5659	IDC
A71	HistoryVal T324 new
A72	EpisodeDescription T324 FirstOccurrence
T325	Site 5651 5655	left
R77	SiteOf Arg1:T325 Arg2:T324	
T326	Radiology 5828 5831	MRI
A73	IntentVal T326 diagnosis
T327	Site 5821 5827	breast
T328	Laterality 5806 5815	Bilateral
R78	LateralityOfSite Arg1:T328 Arg2:T327	
R79	SiteOf Arg1:T327 Arg2:T326	
T329	ClinicalCondition 7672 7682	malignancy
A74	HistoryVal T329 new
A75	EpisodeDescription T329 FirstOccurrence
T330	Site 7644 7650	breast
T331	Laterality 7639 7643	Left
R80	LateralityOfSite Arg1:T331 Arg2:T330	
R81	SiteOf Arg1:T330 Arg2:T329	
T332	RadPathResult 7684 7693	BI-RADS 6
A76	RadPathResultVal T332 InitialCancerDiagnosis
R82	SiteOf Arg1:T330 Arg2:T332	
T333	Site 7703 7709	breast
T334	Laterality 7697 7702	Right
T335	RadPathResult 7719 7728	BI-RADS 2
A77	RadPathResultVal T335 NoDisease
R83	SiteOf Arg1:T333 Arg2:T335	
R84	LateralityOfSite Arg1:T334 Arg2:T333	
T336	GenomicTestResult 7962 7974	ATM mutation
T337	Histology 7831 7841	malignancy
A78	HistoryVal T337 new
A79	EpisodeDescription T337 FirstOccurrence
T338	Site 7824 7830	breast
T339	Laterality 7819 7823	left
R85	LateralityOfSite Arg1:T339 Arg2:T338	
R86	SiteOf Arg1:T338 Arg2:T337	
T340	TNM 7999 8003	T2NX
A80	HistoryVal T340 new
A81	EpisodeDescription T340 FirstOccurrence
T341	BiomarkerName 8004 8006	ER
A82	HistoryVal T341 new
A83	EpisodeDescription T341 FirstOccurrence
T342	BiomarkerResult 8006 8007	+
A84	HistoryVal T342 new
A85	EpisodeDescription T342 FirstOccurrence
A86	BiomarkerResultVal T342 Positive
R87	BiomarkerRel Arg1:T342 Arg2:T341	
T343	BiomarkerName 8008 8010	PR
A87	HistoryVal T343 new
A88	EpisodeDescription T343 FirstOccurrence
T344	BiomarkerResult 8010 8011	-
A89	HistoryVal T344 new
A90	EpisodeDescription T344 FirstOccurrence
A91	BiomarkerResultVal T344 Negative
R88	BiomarkerRel Arg1:T343 Arg2:T344	
T345	BiomarkerName 8012 8016	HER2
A92	HistoryVal T345 new
A93	EpisodeDescription T345 FirstOccurrence
T346	BiomarkerResult 8017 8025	negative
A94	HistoryVal T346 new
A95	EpisodeDescription T346 FirstOccurrence
A96	BiomarkerResultVal T346 Negative
R89	BiomarkerRel Arg1:T345 Arg2:T346	
T347	Site 8031 8037	breast
T348	Laterality 8026 8030	left
R90	LateralityOfSite Arg1:T348 Arg2:T347	
R91	SiteOf Arg1:T347 Arg2:T340	
T349	Pathology 8102 8105	FNA
A97	IntentVal T349 staging
T350	Site 8118 8130	axillary LNs
T351	Laterality 8113 8117	left
R92	LateralityOfSite Arg1:T351 Arg2:T350	
R93	SiteOf Arg1:T350 Arg2:T349	
T352	ClinicalCondition 8154 8160	cancer
A98	NegationModalityVal T352 negated
R94	TestOrProcedureReveals Test:T349 Desc:T352	
T353	GenomicTestResult 8177 8189	ATM mutation
A99	HistoryVal T353 new
A100	EpisodeDescription T353 FirstOccurrence
T354	ProcedureName 8248 8258	mastectomy
A101	NegationModalityVal T354 hypothetical_in_future
T355	ProcedureName 8271 8296	breast conserving surgery
A102	NegationModalityVal T355 hypothetical_in_future
A103	IntentVal T355 treatment-curative
A104	TreatmentTypeVal T355 local
A105	TreatmentCategory T355 Others
A106	IntentVal T354 treatment-curative
A107	TreatmentTypeVal T354 local
A108	TreatmentCategory T354 Others
R95	NotUndergoneBecauseOf Arg1:T355 Reason:T353	
R96	TestOrProcedureConductedForProblem Test:T354 Prob:T340	
T356	GenomicTest 8347 8357	Mammaprint
T357	GenomicTestResult 8358 8367	High Risk
R97	ResultOfTest Desc:T357 Test:T356	
T358	TreatmentType 8389 8401	chemotherapy
A109	NegationModalityVal T358 hypothetical_in_future
T359	ProcedureName 8480 8487	surgery
T360	LymphNodeInvolvement 8546 8559	node positive
A110	NegationModalityVal T360 hypothetical_in_future
T361	MedicationName 8506 8514	Taxotere
A111	NegationModalityVal T361 hypothetical_in_future
A112	TreatmentTypeVal T361 adjuvant
A113	TreatmentIntentVal T361 curative
A114	TreatmentCategory T361 AntiNeoPlastics
T362	MedicationName 8519 8526	Cytoxan
A115	NegationModalityVal T362 hypothetical_in_future
A116	TreatmentTypeVal T362 adjuvant
A117	TreatmentIntentVal T362 curative
A118	TreatmentCategory T362 AntiNeoPlastics
T363	MedicationRegimen 8576 8585	AC-Taxol.
A119	NegationModalityVal T363 hypothetical_in_future
A120	TreatmentTypeVal T363 adjuvant
A121	TreatmentIntentVal T363 curative
R98	TreatmentAdministeredForProblem Treatment:T363 Prob:T360	
T364	LymphNodeInvolvement 8451 8464	node negative
A122	NegationModalityVal T364 hypothetical_in_future
R99	TreatmentAdministeredForProblem Treatment:T361 Prob:T364	
R100	TreatmentAdministeredForProblem Treatment:T362 Prob:T364	
T365	TreatmentType 8653 8665	chemotherapy
A123	NegationModalityVal T365 hypothetical_in_future
A124	TreatmentTypeVal T365 adjuvant
A125	TreatmentIntentVal T365 curative
T366	ProcedureName 8688 8695	surgery
A126	NegationModalityVal T366 hypothetical_in_future
A127	IntentVal T366 treatment-curative
A128	TreatmentTypeVal T366 local
T367	Symptom 8883 8893	toxicities
A129	NegationModalityVal T367 hypothetical_in_future
T368	TreatmentType 8906 8920	chemotherapies
A130	NegationModalityVal T368 hypothetical_in_future
A131	TreatmentTypeVal T368 adjuvant
A132	TreatmentIntentVal T368 curative
R101	ConditionOrTreatmentCausesProblem Treatment:T368 Prob:T367	
T369	ProcedureName 8979 8986	surgery
A133	NegationModalityVal T369 hypothetical_in_future
A134	IntentVal T369 treatment-curative
A135	TreatmentTypeVal T369 local
A136	TreatmentCategory T369 Others
T370	ClinicalCondition 9003 9016	breast cancer
T371	BiomarkerName 9020 9037	estrogen receptor
A139	HistoryVal T371 new
A140	EpisodeDescription T371 FirstOccurrence
T372	BiomarkerResult 9038 9046	positive
A141	HistoryVal T372 new
A142	EpisodeDescription T372 FirstOccurrence
A143	BiomarkerResultVal T372 Positive
R102	BiomarkerRel Arg1:T372 Arg2:T371	
R103	TumorDesc TumorDetails:T371 Desc:T370	
T373	TreatmentType 9118 9134	hormonal therapy
A144	TreatmentTypeVal T373 adjuvant
T374	Duration 9095 9105	five years
R104	HappensOverlapping Arg1:T373 Arg2:T374	
R105	TreatmentAdministeredForProblem Treatment:T373 Prob:T371	
T375	ClinicalTrial 9185 9189	SOFT
T376	ClinicalTrial 9194 9198	TEXT
T377	DiseaseState 9563 9581	distant recurrence
T378	ClinicalTrial 9625 9629	SOFT
T379	PatientCharacteristics 9356 9369	premenopausal
T380	MedicationName 9530 9539	tamoxifen
A149	TreatmentTypeVal T380 adjuvant
A150	TreatmentIntentVal T380 others
A152	NegationModalityVal T373 planned_in_future
A153	TreatmentContinuityVal T373 planned
T381	TreatmentType 9434 9446	chemotherapy
T382	TreatmentType 9494 9513	aromatase inhibitor
T383	MedicationName 9695 9704	tamoxifen
A147	TreatmentTypeVal T383 adjuvant
A148	TreatmentIntentVal T383 others
A151	TreatmentCategory T383 AntiNeoPlastics
T384	MedicationRegimen 9725 9759	tamoxifen plus ovarian suppression
A154	TreatmentTypeVal T384 adjuvant
A155	TreatmentIntentVal T384 others
T385	MedicationRegimen 9776 9811	exemestane plus ovarian suppression
A157	TreatmentIntentVal T385 others
T386	MedicationName 9825 9834	tamoxifen
A158	TreatmentTypeVal T386 adjuvant
A159	TreatmentIntentVal T386 others
A160	TreatmentCategory T386 AntiNeoPlastics
T387	MedicationRegimen 9845 9879	tamoxifen plus ovarian suppression
A161	TreatmentTypeVal T387 adjuvant
A162	TreatmentIntentVal T387 others
T388	DiseaseState 9971 9989	distant recurrence
A163	NegationModalityVal T388 hypothetical_in_future
T389	MedicationRegimen 9995 10030	exemestane plus ovarian suppression
A164	TreatmentTypeVal T389 adjuvant
A165	TreatmentIntentVal T389 others
T390	MedicationRegimen 10060 10094	tamoxifen plus ovarian suppression
A166	TreatmentTypeVal T390 adjuvant
A167	TreatmentIntentVal T390 others
T391	TreatmentType 9938 9950	chemotherapy
T392	BiomarkerName 9903 9907	HER2
T393	BiomarkerResult 9908 9916	negative
R106	BiomarkerRel Arg1:T393 Arg2:T392	
T394	ClinicalTrial 10162 10166	TEXT
T395	TreatmentType 10232 10248	hormonal therapy
A168	NegationModalityVal T395 planned_in_future
T396	ProcedureName 10255 10262	surgery
A169	NegationModalityVal T396 planned_in_future
A170	IntentVal T396 treatment-curative
A171	TreatmentTypeVal T396 local
A172	TreatmentCategory T396 Others
A1	ContinuityVal T210 new
A2	ContinuityVal T370 new
A137	GenomicTestType T356 GeneExpression
T397	Age 23 25	32
T398	Age 7947 7949	32
R108	TestOrProcedureReveals Test:T259 Desc:T242	
A138	TreatmentContinuityVal T389 unclear
A174	TreatmentContinuityVal T391 unclear
R109	TestOrProcedureReveals Test:T271 Desc:T285	
R110	TestOrProcedureReveals Test:T271 Desc:T287	
R111	SiteOf Arg1:T282 Arg2:T271	
R112	SiteOf Arg1:T288 Arg2:T271	
R114	SiteOf Arg1:T278 Arg2:T286	
R115	TestOrProcedureReveals Test:T271 Desc:T290	
R116	TestOrProcedureReveals Test:T271 Desc:T277	
R117	SiteOf Arg1:T253 Arg2:T251	
R118	TestOrProcedureReveals Test:T251 Desc:T262	
T399	Site 1964 1969	right
R119	SiteOf Arg1:T399 Arg2:T281	
A175	NegationModalityVal T297 hypothetical_in_future
T400	Symptom 4025 4036	sore throat
A176	NegationModalityVal T400 negated
T401	Symptom 4038 4054	nasal congestion
A177	NegationModalityVal T401 negated
T402	Symptom 4056 4070	vision changes
A178	NegationModalityVal T402 negated
T403	Symptom 4072 4077	cough
A179	NegationModalityVal T403 negated
T404	Symptom 4079 4089	chest pain
A180	NegationModalityVal T404 negated
T405	Symptom 4091 4098	dyspnea
A181	NegationModalityVal T405 negated
T406	Symptom 4100 4106	nausea
A182	NegationModalityVal T406 negated
T407	Symptom 4108 4116	vomiting
A183	NegationModalityVal T407 negated
T408	Symptom 4118 4132	abdominal pain
A184	NegationModalityVal T408 negated
T409	Symptom 4134 4143	headaches
A185	NegationModalityVal T409 negated
T410	Symptom 4145 4151	fevers
A186	NegationModalityVal T410 negated
T411	Symptom 4157 4192	change in bladder or bowel function
A187	NegationModalityVal T411 negated
R120	TestOrProcedureReveals Test:T359 Desc:T364	
R121	TestOrProcedureReveals Test:T359 Desc:T360	
A196	NegationModalityVal T389 hypothetical_in_future
R57	SiteOf Arg1:T282 Arg2:T284	
A197	ExperiencerVal T375 others
A198	ExperiencerVal T376 others
A188	ExperiencerVal T381 others
T412	TreatmentType 9467 9486	ovarian suppression
A199	ExperiencerVal T412 others
A189	ExperiencerVal T382 others
A192	ExperiencerVal T380 others
A146	ExperiencerVal T377 others
A200	NegationModalityVal T377 negated
A201	ExperiencerVal T378 others
T413	DiseaseState 9646 9679	8-year disease-free survival rate
A202	NegationModalityVal T413 hypothetical_in_future
A203	ExperiencerVal T413 others
A190	ExperiencerVal T383 others
A191	ExperiencerVal T384 others
A156	ExperiencerVal T385 others
A193	ExperiencerVal T386 others
A194	ExperiencerVal T387 others
A204	ExperiencerVal T388 others
A195	ExperiencerVal T391 others
A173	ExperiencerVal T394 others
T414	RadPathResult 1083 1093	small node
A205	RadPathResultVal T414 Unclear
R60	ResultOfTest Desc:T414 Test:T244	
T415	RadPathResult 1137 1149	larger nodes
A206	RadPathResultVal T415 Unclear
R122	ResultOfTest Desc:T415 Test:T244	
T416	RadPathResult 2212 2231	cortical thickening
A207	RadPathResultVal T416 Unclear
R123	ResultOfTest Desc:T416 Test:T271	
A208	GenomicTestType T215 Germline
A209	GenomicTestType T295 Germline
A210	GenomicTestType T323 Germline
A211	GenomicTestType T336 Germline
A212	GenomicTestType T353 Germline
R113	TestOrProcedureReveals Test:T271 Desc:T286	
A48	DiseaseStateVal T377 progression-recurrence
A49	DiseaseStateVal T413 remission
A213	DiseaseStateVal T388 progression-recurrence
R107	SizeOf Arg1:T228 Arg2:T229	
R124	SizeOf Arg1:T237 Arg2:T236	
R125	SizeOf Arg1:T277 Arg2:T276	
R126	SizeOf Arg1:T285 Arg2:T284	
R127	SizeOf Arg1:T293 Arg2:T290	
T258	Age 5605 5607	32
T417	hpi_start 0 3	HPI
T418	hpi_end 2651 2652	)
T419	ap_start 7908 7918	Assessment
T420	ap_end 10270 10271	.
